KORU Medical shifts director removal power to shareholders
Rhea-AI Filing Summary
KORU Medical Systems, Inc. reports a governance change approved by its Board of Directors effective August 13, 2026. The company amended Section 3.05 of its Amended and Restated By-laws so that, consistent with the Delaware General Corporation Law, the authority to remove any director rests exclusively with shareholders through an affirmative vote of holders of a majority of the company’s outstanding shares.
The Board states it has never voted to remove a director and has no intention or agreement to do so. The amendment is filed as an exhibit to this report.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 5.03, 9.01
2 items
Item 5.03
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Effective date of bylaw amendment: August 13, 2026
Filing signature date: August 14, 2026
Director removal vote threshold: Majority of outstanding shares
3 metrics
Effective date of bylaw amendment
August 13, 2026
Date the Board’s amendment to Section 3.05 became effective
Filing signature date
August 14, 2026
Date the report was signed by the Chief Executive Officer
Director removal vote threshold
Majority of outstanding shares
Shareholder vote required to remove a director under amended bylaws
Key Terms
Delaware General Corporation Law, Amended and Restated By-laws, Emerging growth company
3 terms
Delaware General Corporation Law regulatory
"in compliance with the Delaware General Corporation Law, the authority to remove a director"
A set of state laws that acts like a rulebook for how corporations are formed, governed, and dissolved in Delaware. It lays out legal duties for company leaders, protections and voting rights for shareholders, and rules for mergers and other big transactions, giving investors clearer expectations about how corporate decisions are made and disputes are resolved—similar to having standardized traffic laws for business behavior.
Amended and Restated By-laws regulatory
"amend Section 3.05 of the Company’s Amended and Restated By-laws"
Emerging growth company regulatory
"Emerging growth company [_] [_] ITEM 5.03"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
FAQ
What governance change did KORU Medical Systems (KRMD) disclose on August 13, 2026?
KORU Medical Systems disclosed a bylaw amendment effective August 13, 2026, placing director removal authority exclusively with shareholders holding a majority of outstanding shares, in line with Delaware General Corporation Law.
Who now has the authority to remove directors at KORU Medical Systems (KRMD)?
The authority to remove a director is now vested exclusively in shareholders, requiring an affirmative vote of holders of a majority of KORU’s outstanding shares, rather than any board-level removal mechanism.
Did KORU Medical Systems’ board intend to remove any director when amending its bylaws?
No. The Board stated it has not previously voted to remove any director and has no intention or agreement to vote to remove any director in connection with this bylaw amendment.
Which section of KORU Medical Systems’ bylaws was amended in this 8-K filing?
KORU Medical Systems amended Section 3.05 of its Amended and Restated By-laws, clarifying that removal of directors requires an affirmative vote of shareholders holding a majority of outstanding shares.
What exhibit was filed with KORU Medical Systems’ (KRMD) 8-K about the bylaw change?
The company filed Exhibit 3.1, titled “Amendment No. 1 to Amended and Restated By-laws of KORU Medical Systems, Inc.,” along with an Inline XBRL cover page data file as Exhibit 104.
AI-generated analysis. How Rhea-AI works. Not financial advice.
